Stockmarket

Number of UK billionaires falls after market turmoil; Japan’s GDP shrinks – business live


Introduction: UK billionaires total falls after market turmoil and non-dom tax clampdown

Good morning, and welcome to our rolling coverage of business, the financial markets and the world economy.

The number of British billionaires has fallen, as the super-rich are hit by stock market turbulence and the end of tax breaks for non-doms.

The Sunday Times’s annual totting-up of Britain’s richest people, just published shows that the number of billionaires slid to 156 this year from 165 in 2024. That’s the sharpest decline in the Rich List’s 37-year-history.

The Sunday Times reports that “falling fortunes” have led many to drop off the list, while others are no longer eligible, having “fled Britain after Labour’s non-dom crackdown”.

Robert Watts, compiler of the Rich List, says:

“Our billionaire count is down and the combined wealth of those who feature in our research is falling.

“We are also finding fewer of the world’s super rich are coming to live in the UK.”

In March 2024, then-chancellor Jeremy Hunt announced plans to axe the UK’s tax breaks for non-doms, which allowed foreign nationals who live in the UK to avoid paying UK tax on their overseas income and gains. One London-based billionaire non-dom left the UK for good on the day of Hunt’s announcement, a tax advisor revealed.

Rachel Reeves tightened the policy in her first budget, before then softening the changes in an attempt to woo the rich.

The Sunday Times has calculated that the combined wealth of the 350 entries on the Rich List has dropped by 3% over the last year, to £772.8bn, the third consecutive drop in collective value.

The entry level flatlines at £350m.

For the fourth successive year, the list is topped by Indian-born industrialist Gopi Hinduja, 85, and family with a fortune of £35.3bn, down from £37.1bn in 2024 due to the drop in the value of their stock market-listed companies. Overall, the Hinduja’s companies operate in automotive, oil and speciality chemicals, banking and finance, IT, cybersecurity, healthcare, trading, infrastructure project development, media and entertainment, power, and real estate.

David and Simon Reuben and family have risen to second place, with £26.8bn (up from £25bn last year) overtaking Sir Leonard Blavatnik, whose wealth has dropped to £25.725bn (from £29.2bn) due to a drop in his stake in Warner Music Group,

There are some eye-catching fallers on the list too, including businessman Sir Jim Ratcliffe. He’s dropped from 4th to 7th, after his wealth declined to £17bn from £23,5bn in 2024.

Britain’s billionaires will have gained wealth in the last few weeks as global stock markets recovered from their plunge in early April, when Donald Trump launched his global trade war.

The agenda

  • 9.30am BST: Hong Kong GDP report for Q1 2025

  • 10am BST: Eurozone trade balance report for March

  • 1.30pm BST: US building permits and housing starts data for April

  • 3pm BST: University of Michigan survey of US consumer sentiment for May (flash estimate)

Share

Updated at 

Key events

Novo Nordisk boss steps down following ‘market challenges’ and falling share price

There’s drama in the pharmaceuticals world, where the boss of Denmark’s Novo Nordisk has unexpectedly resigned.

Novo Nordisk, which produces the weight loss drug Wegovy and the diabetes medication Ozempic, says Lars Fruergaard Jørgensen is stepping down “as per mutual agreement” with the company’s board.

Jørgensen appears to be leaving in response to rising competion in the weight loss drug market, which has led to Novo Nordisk’s share price more than halving over the last year.

The company says that Novo Nordisk Foundation Board recently “initiated a dialogue with the Novo Nordisk Board on the merits of an accelerated CEO succession”, adding:

Considering the recent market challenges, the share price decline, and the wish from the Novo Nordisk Foundation, the Novo Nordisk Board and Lars Fruergaard Jørgensen have jointly concluded that initiating a CEO succession is in the best interest of the company and its shareholders.

Lars Fruergaard Jørgensen has agreed to continue as CEO for a period to support a smooth transition to new leadership.

Just last week, Novo Nordisk cut its annual revenue and profit forecasts, as it faced rising competition from US rival Eli Lilly, which makes the diabetes and obesity drugs Mounjaro and Zepbound.

Share





READ SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.